医学
彭布罗利珠单抗
伦瓦提尼
卵巢癌
肿瘤科
内科学
临床研究阶段
妇科
癌症
临床试验
免疫疗法
甲状腺癌
作者
Antonio González-Martı́n,Hyun Cheol Chung,Esma Saâda-Bouzid,Eduardo Yáñez,Hélène Senellart,Philippe A. Cassier,Bristi Basu,Bradley R. Corr,Eugenia Girda,Corina E. Dutcus,Chinyere E. Okpara,Razi Ghori,Fan Jin,Roman Groisberg,Zarnie Lwin
标识
DOI:10.1016/j.ygyno.2024.04.011
摘要
The phase 2, multicohort, open-label LEAP-005 study evaluated lenvatinib plus pembrolizumab in patients with previously treated advanced solid tumors. We report outcomes from the ovarian cancer cohort.
科研通智能强力驱动
Strongly Powered by AbleSci AI